Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.07 USD -0.60 (-9.00%)

At closeNov 12, 2026, 4:00 PM EST

6.15 +0.08 +1.32%

After hours · Nov 12, 4:00 PM ET

6.00 Day range 6.50
1.95 52-week range 12.43
YTD
+206.57%
1 year
+194.66%

Discussion (3506)

Sign in to join the discussion

frank fager IBRX 8 months ago #1672

I laugh every day price needs to do XYZ needs to hold X I LMAO daily at the wasted energy and stupidity.

Where will the price be 6mo 1 2 3 5 10
Years not what it will be today tomorrow and in week.

I am 68 retires at 52 and I invest I invested 2.5 million in IBRX 520,000 share never sold a single share

frank fager IBRX 8 months ago #1673

"Keytruda’s rapid, broad approval for over 20 cancers stems from its unique mechanism as a PD-1 inhibitor that unleashes the immune system across many tumor types, combined with FDA accelerated approvals, Breakthrough Therapy designations, and large-scale, adaptive clinical trials (KEYNOTE studies). It was often approved based on early, dramatic phase 1 data"

So why hasn't Anktiva been granted the same???????

Big Pharma
MSM
FDA ,corruption

frank fager IBRX 8 months ago #1674

If and we should get Keytruda size approvals stock goes triple digits

frank fager IBRX 8 months ago #1679

Larry OMG Trump is busy we are at war

Send to RFK Jr Makary Bhattacharya

frank fager IBRX 8 months ago #1680

GM from Scottsdale Az and back to sleep for me :) it's 2:40am